{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:58:25Z","timestamp":1781272705831,"version":"3.54.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    <jats:italic>Fonsecaea pedrosoi<\/jats:italic>\n                    , a pathogenic fungus within the order Chaetomycosis of the family Dematiaceae, is the primary causative agent of Chromoblastomycosis (CBM). Its clinical manifestations are diverse and lack specificity, often being confused with other skin diseases, which can easily lead to misdiagnosis or missed diagnosis. This article reports a case of a 36-year-old immunocompromised female with chronic infection caused by\n                    <jats:italic>F. pedrosoi<\/jats:italic>\n                    following minor trauma to the right knee. The patient presented with plaque-like hyperplasia, pruritus, desquamation, and suppuration of the local skin over the right knee, with persistent and refractory clinical course. The definite diagnosis was ultimately established through mycological, histopathological, and molecular biological examinations, followed by appropriate therapeutic intervention. This case indicates that chromoblastomycosis is prone to missed or delayed diagnosis due to its atypical clinical manifestations. Moreover, immunocompromised patients are more likely to experience prolonged disease course and slow recovery, highlighting the critical importance of accurate diagnosis and rational selection of treatment regimens. Combined with a literature review, it analyzes the clinical characteristics and key points in diagnosis and treatment of the disease, explores approaches to strengthen the awareness of clinical monitoring, and aims to improve the overall public health awareness of the disease.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2026.1842447","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:53:28Z","timestamp":1779944008000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Chromoblastomycosis caused by Fonsecaea pedrosoi: a case report and literature review"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuyun","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, The General Hospital of Western Theater Command of People\u2019s Liberation Army (PLA)","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The General Hospital of Western Theater Command of People\u2019s Liberation Army (PLA)","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The General Hospital of Western Theater Command of People\u2019s Liberation Army (PLA)","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqing","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The General Hospital of Western Theater Command of People\u2019s Liberation Army (PLA)","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The General Hospital of Western Theater Command of People\u2019s Liberation Army (PLA)","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1128\/cmr.00032-16","article-title":"Chromoblastomycosis","volume":"30","author":"Queiroz-Telles","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/dth.12149","article-title":"Successful sequential treatment with itraconazole and ALA-PDT for chromoblastomycosis because of Alternaria alternata","volume":"27","author":"Liu","year":"2014","journal-title":"Dermatol Ther"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/cid\/ciu168","article-title":"Topical application of imiquimod as a treatment for chromoblastomycosis","volume":"58","author":"de Sousa","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref4","first-page":"53","article-title":"Sobre quarto casos de dermatite verrucosa produzida por Phialophora verrucosa","volume":"11","author":"Pedroso","year":"1920","journal-title":"An Paul Med Cir"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1590\/1806-9282.65.9.1130","article-title":"Chromoblastomycosis: a neglected disease","volume":"65","author":"Teles Filho","year":"2019","journal-title":"Rev Assoc Med Bras"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1396224","article-title":"Chromoblastomycosis caused by Alternaria infectoria, concurrent with myiasis, in a recipient of a kidney transplant: a compelling case report","volume":"11","author":"Mahmoudi","year":"2024","journal-title":"Front Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/j.1365-2230.2009.03415.x","article-title":"Chromoblastomycosis: clinical presentation and management","volume":"34","author":"Ameen","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1099\/jmm.0.065292-0","article-title":"First report of rhinosinusitis caused by Neoscytalidium dimidiatum in Iran","volume":"63","author":"Bakhshizadeh","year":"2014","journal-title":"J Med Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/ajd.13262","article-title":"Disseminated phaeohyphomycosis caused by Cyphellophora ludoviensis: a novel case report from Iran","volume":"61","author":"Layegh","year":"2020","journal-title":"Australas J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3969\/j.issn.1673-3827.2020.02.009","article-title":"Retrospective analysis of chromoblastomycosis in mainland China: a review of 52 cases","volume":"15","author":"Sun","year":"2020","journal-title":"Chin J Mycol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.4269\/ajtmh.19-0885","article-title":"Case report: chronic fungal meningitis masquerading as tubercular meningitis","volume":"103","author":"Hesarur","year":"2020","journal-title":"Am J Trop Med Hygiene"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3171\/2011.5.Peds1112","article-title":"An unusual infection, an unusual outcome\u2014Fonsecaea pedrosoi cerebral granuloma","volume":"8","author":"Madhugiri","year":"2011","journal-title":"J Neurosurg Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/0976-3147.98237","article-title":"A rare concomitant tubercular and Fonsecaea pedrosoi fungal infection of the skull base","volume":"3","author":"Suchanda","year":"2012","journal-title":"J Neurosci Rural Pract"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1183\/09031936.06.00144505","article-title":"An unusual case of mediastinal mass due toFonsecaea pedrosoi","volume":"28","author":"Singh","year":"2006","journal-title":"Eur Respir J"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4103\/0255-0857.115232","article-title":"A case report of an uncommon phaeoid fungal infection in nasal polyposis and review of literature","volume":"31","author":"Sa","year":"2013","journal-title":"Indian J Med Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/13693780802538001","article-title":"Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment","volume":"47","author":"Queiroz-Telles","year":"2009","journal-title":"Med Mycol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3855\/jidc.5312","article-title":"Chromoblastomycosis due to Fonsecaea pedrosoi: an old wine in a rare bottle","volume":"9","author":"Khan","year":"2015","journal-title":"J Infect Dev Count"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3969\/j.issn.1673-3827.2012.06.009","article-title":"A case of chromoblastomycosis caused by Fonsecaea pedrosoi and literature review","volume":"7","author":"Liu","year":"2012","journal-title":"Chin J Mycol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1590\/abd1806-4841.20187321","article-title":"Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update","volume":"93","author":"Brito","year":"2018","journal-title":"An Bras Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"458","DOI":"10.4066\/amj.2013.1806","article-title":"Chromoblastomycosis \u2013 a clinical mimic of squamous carcinoma","volume":"6","author":"Roy","year":"2013","journal-title":"Australasian Med J"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.5146\/tjpath.2013.01197","article-title":"Cutaneous chromoblastomycosis mimicking tuberculosis verrucosa cutis: look for copper pennies!","volume":"31","author":"Bandyopadhyay","year":"2015","journal-title":"Turk J Pathol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4067\/s0716-10182017000400404","article-title":"Chromoblastomycosis - clinical and microbiological characteristics of a neglected disease","volume":"34","author":"R","year":"2017","journal-title":"Rev Chilena Infectol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1842447\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:19:30Z","timestamp":1781270370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1842447\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":22,"alternative-id":["10.3389\/fmed.2026.1842447"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1842447","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"article-number":"1842447"}}